7020 Performance status and interval from first-line docetaxel-based chemotherapy to progression are significant prognostic factors in patients with castration-resistant prostate cancer receiving second-line chemotherapy

✍ Scribed by Loriot, Y.; Massard, C.; Gross-Goupil, M.; De La Motte Rouge, T.; Bossi, A.; Escudier, B.; Chauchereau, A.; Fizazi, K.

• Book ID: 122063516
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 50 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(09)71398-9